¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chronic toxicity test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • bone conduction test
    »ÀÀüµµ°Ë»ç, °ñÀüµµ°Ë»ç
  • balloon occlusion test
    dz¼±Æó¼â°Ë»ç
  • breath holding test
    ¼ûÂü±â°Ë»ç, È£ÈíÁßÁö°Ë»ç
  • bronchial challenge test
    ±â°üÁöÀ¯¹ß°Ë»ç
  • clearance test
    û¼ÒÀ²½ÃÇè
  • clock-drawing test
    ½Ã°è±×¸®±â°Ë»ç
  • cold pressure test
    ÇÑ·©¾Ð¹Ú°Ë»ç
  • complement fixation inhibition test
    º¸Ã¼°áÇÕ¾ïÁ¦°Ë»ç
  • complement fixation test
    º¸Ã¼°áÇÕ°Ë»ç
  • contraction stress test
    ¼öÃàÀڱذ˻ç
  • Coombs¡¯ test
    ÄñÁî°Ë»ç
  • coordination test
    ¼Õ¹ßÇùÁ¶±â´É°Ë»ç
  • cover-uncover test
    °¡¸²¾È°¡¸²°Ë»ç
  • creatinine clearance test
    Å©·¹¾ÆÆ¼´Ñû¼ÒÀ²°Ë»ç
  • catalase test
    īŻ¶ó¾ÆÁ¦°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • statistical test
    Åë°è°ËÁ¤
  • test tube
    ½ÃÇè°ü
  • thematic apperception test
    ÁÖÁ¦Åë°¢°Ë»ç
  • tilt test
    ±â¸³°æ»ç°Ë»ç
  • treadmill test
    Æ®·¹µå¹Ð°Ë»ç
  • triple test
    »ïÁß°Ë»ç
  • triple marker test
    »ïÁßÇ¥Áö°Ë»ç
  • tuberculin test
    Åõº£¸£Ä𸰰˻ç
  • urea breath test
    ¿ä¼Ò³¯¼û°Ë»ç
  • vestibular function test
    ¾È¶ã±â´É°Ë»ç, ÀüÁ¤±â´É°Ë»ç
  • visual acuity test
    ½Ã·Â°Ë»ç
  • water deprivation test
    ¼öºÐÁ¦ÇѰ˻ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • bone marrow function test
    °ñ¼ö±â´É°Ë»ç
  • breath holding test
    È£ÈíÁßÁö½ÃÇè, È£ÈíÁßÁö°Ë»ç
  • bulbocavernous evoked-response test
    ¸Á¿ïÇØ¸éü±ÙÀ¯µµ¹ÝÀÀ°Ë»ç
  • bulbocavernous reflex latency test
    ¸Á¿ïÇØ¸éü±Ù¹Ý»ç½Ã°£ÃøÁ¤°Ë»ç
  • caloric test
    ¿Âµµ´«¶³¸²°Ë»ç
  • carbohydrate tolerance test
    ź¼öÈ­¹°³»¼º½ÃÇè
  • carbon monoxide hemoglobin test
    ÀÏ»êȭź¼ÒÇì¸ð±Û·Îºó°Ë»ç
  • catalase test
    īŻ¶ó¾ÆÁ¦°Ë»ç
  • cell-mediated lympholysis test
    ¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
  • challenge test
    À¯¹ß°Ë»ç
  • chelation test
    ų·¹ÀÌÆ®È­°Ë»ç
  • chemiluminescence test
    È­Çй߱¤°Ë»ç
  • chemstrip test
    È­Çжì°Ë»ç
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • children apperception test
    ¾Æµ¿Åë°¢°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Du test
    Du °Ë»ç (ÁÖÀÇ : u ´Â À­Ã·ÀÚÀÓ)
  • Eleks gel-precipitin test
    ¿¤·ºÅ©ÇÑõÆòÆÇħ°­¹ý (µðÇÁÅ׸®¾Æµ¶¼Ò µ¿Á¤¹ý)
  • Falcon assay screening test
    ÆÈÄܺм®¼±º°½ÃÇè
  • Farnworth D-15 test
    ÆÄ¸¥¿ö½º15»ö»ó°Ë»ç
  • Farnworth-Munsell 100 hue test
    ÆÄ¸¥¿ö½º-¹®¼¿ 100»ö»ó°Ë»ç
  • Freda test
    ÇÁ·¹´Ù½ÃÇè
  • Frei s test
    ÇÁ¶óÀ̽ÃÇè<¹ÝÀÀ>
  • Frei test
    ÇÁ¶óÀ̽ÃÇè
  • Freis test
    ÇÁ¶óÀ̰˻ç
  • Friedman test
    ÇÁ¸®µå¸¸½ÃÇè
  • Frye test
    ÇÁ¶óÀ̽ÃÇè
  • GTT= glucose tolerance test
    ´çºÎÇÏ °Ë»ç.
  • Gelle test
    °Ö·¹°Ë»ç
  • Gerhardt ferric chloride test
    °Ô¸£Çϸ£Æ® ¿°È­Ã¶½ÃÇè
  • Gibson-Cooke test
    ±é½¼-ÄîÅ© ½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • chronic conjunctivitis
    ¸¸¼º°á¸·¿°
  • chronic constrictive pericarditis
    ¸¸¼º±äÃ༺ ½É¸·¿°(Ø·àõÑÌõêàõãýدæú).
  • chronic cystic mastitis
    ¸¸¼º³¶¼º À¯¹æ¿°(¡­³¶¼ºÀ¯¹æ¿°).
  • chronic cystitis
    ¸¸¼º¹æ±¤¿°.
  • chronic dacryocystitis
    ¸¸¼º´«¹°ÁÖ¸Ó´Ï¿°Áõ, ¸¸¼º´©³¶¿°
  • chronic dermatitis
    ¸¸¼º ÇǺο°
  • chronic dilutional hyponatremia
    ¸¸¼ºÈñ¼®¼º Àú³ªÆ®·ýÇ÷Áõ(Ø·àõýüà·àõ¡­úìñø) .
  • chronic empyema
    ¸¸¼º³óÈä.
  • chronic epididymitis
    ¸¸¼º ºÎ°íȯ¿°
  • chronic exposure
    ¸¸¼ºÇÇÆø
  • chronic factitious disorder with physical symptoms
    ¸¸¼º ÀΰøÀû Àå¾Ö ½ÅüÀû
  • chronic familial jaundice
    ¸¸¼º°¡Á·¼º Ȳ´Þ(¡­Ê«ðéàõüÜÓ¸).
  • chronic fatigue syndrome
    ¸¸¼º ÇÇ·ÎÁõÈıº
  • chronic gastritis
    ¸¸¼ºÀ§¿°(¡­êÖæú).
  • chronic glaucoma
    ¸¸¼º³ì³»Àå
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • resorcinol test
    ¸®Á¶¸£½Ã³î ½ÃÇè(ãËúÐ)
  • reversible boundary spreading test
    °¡¿ª °æ°è ºÐ»ê ½ÃÇè(ʦæ½ÌÑÍ£ÝÂߤãËúÐ)
  • Rice test
    ¶óÀ̽º ½ÃÇè(ãËúÐ)
  • ring test
    °í¸®½ÃÇè(ãËúÐ)
  • Rothera's test
    ·ÎÅ×¶ó ½ÃÇè(ãËúÐ)
  • Schiff's test
    ½¬ÇÁ ½ÃÇè(ãËúÐ)
  • Schilling test
    ½¯¸µ ½ÃÇè(ãËúÐ)
  • seliwanoff's test
    ¼¿¸®¹Ù³ëÇÁ ½ÃÇè(ãËúÐ)
  • SSA test
    SSA ½ÃÇè(ãËúÐ) (å²)
  • sulfosalicylic acid test
    ¼³Æ÷»ì¸®½Ç»ê(ß«)
  • Sulkowitch test
    ¼úÄÚºñÄ¡ ½ÃÇè(ãËúÐ)
  • suppression test
    ¾ï¾Ð ½ÃÇè(åääâãËúÐ)
  • test meal
    ½ÃÇè½Ä(ãËúÐãÝ)
  • thymol turbidity test
    ŸÀ̸ô ȥʵµ ½ÃÇè (ûèöúÓøãËúÐ)
  • Tollen's test
    Åç·» ½ÃÇè(ãËúÐ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
PS test Pancreozymin-Secretion test
  = combined secretin-CCK test
AAT Aachen Aphasia Test; academic aptitude test; alanine aminotransferase; alkylating agent therapy; alp...
AST allergy serum transfer; angiotensin sensitivity test; anterior spinothalamic tract; antistreptolysin...
CPT carnitine palmityl transferase; carotid pulse tracing; chest physiotherapy; child protection team; c...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CLL B-chronic lymphocytic leukaemia
CRF CHRONIC RENAL FAILURE
CAH Chronic Active Hepatitis
C.A.H. Chronic Aggressive Hepatitis
CAO Chronic Airflow Obstruction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic nonspecific dermatitis
    ¸¸¼º ºñƯÀ̼º ÇǺο°
  • chronic organic brain syndrome
    ¸¸¼º ±âÁú¼º ³ú ÁõÈıº
  • chronic osteomyelitis
    ¸¸¼º °ñ¼ö¿°
    ¾àÇÑ Àڱؿ¡ ÀÇÇØ »ý±â¸ç ÁÖº¯¿¡ °ñ Çü¼ºÀ» µ¿¹ÝÇÑ °ñ¸·ÀÇ ±¹¼ÒÀû Áõ»óÀÌ´Ù. °ÅÀÇ ÀþÀº »ç¶÷¿¡¼­ ¹ß»ýÇϸç, È£¹ßºÎ´Â °æ°ñÀÇ Àü¸é°ú ÇϾÇÀÌ´Ù. Ä¡Åë°ú »óÇϾÇÀÇ ÅëÁõÀÌ ³ªÅ¸³­´Ù. ¶§·Î »óÃþÀÇ ¿¬Á¶Á÷ÀÇ °¨¿°À̳ª ºÀ¿ÍÁ÷¿°ÀÇ °á°ú·Î »ý±ä´Ù.
  • chronic otitis media
    ¸¸¼º ÁßÀÌ¿°
  • chronic pain
    ¸¸¼º ÅëÁõ, ¸¸¼º µ¿Åë
    Àå¾Ö³ª ÁúȯÀÇ ´Ù¸¥ ¸éÀÌ ÇØ°áµÉ ¶§±îÁö Áö¼ÓµÇ´Â ÅëÁõÀ¸·Î¼­ Ư¡ÀûÀ¸·Î 6°³¿ù ÀÌ»ó Áö¼ÓµÇ°Å³ª ±Þ¼º ¿Ü»óÀ̳ª ÅëÁõÀÌ Ä¡À¯µÇ´Â µ¥ ÇÊ¿äÇÑ Á¤»óÀûÀÎ ½Ã°£ ÀÌ»óÀ¸·Î Áö¼ÓµÈ´Ù. Çൿ ¹× Á¤½Å»çȸÀû ¹ÝÀÀÀ» µ¿¹ÝÇÏ´Â ºÒÀ¯ÄèÇÑ °¨°¢, Áö°¢ ¹× Á¤½ÅÀû °æÇè°ú °ü·ÃµÉ ¼ö ÀÖ´Ù.
  • chronic pain cycle
    ¸¸¼º µ¿Åë ¼øÈ¯
  • chronic pain syndrome
    ¸¸¼º ÅëÁõ ÁõÈıº, ¸¸¼º µ¿Åë ÁõÈıº
  • chronic paroxysmal hemicrania
    ¸¸¼º ¹ßÀÛ¼º ÆíµÎÅë, ¸¸¼º ¹ßÀÛ¼º ¹ÝµÎÁõ
    ´« ÁÖÀ§¿¡ ÁýÁßµÇ¾î »´À̳ª ÃøµÎºÎ·Î ¹æ»çµÇ´Â µå¹® ÇüÅÂÀÇ Áö¼ÓÀûÀÎ ÆíÃø¼º µÎÅëÀ¸·Î¼­ °æ°¨µÇÁö ¾ÊÀº ä ¼ö³â µ¿¾È ÇÏ·ç¿¡ 4-12ȸ¾¿ 5-60ºÐ Á¤µµ Áö¼ÓµÈ´Ù. Áý¶ô¼º µÎÅë
  • chronic pathologic pain
    ¸¸¼º º´¸®Àû µ¿Åë
  • chronic periapical
    ¸¸¼º ±Ù´Ü¼º
  • chronic periodontitis
    ¸¸¼º Ä¡ÁÖ¿°
  • chronic pharyngitis
    ¸¸¼º Àεο°
  • chronic polymorphous angiitis
    ¸¸¼º ´ÙÇü¼º Ç÷°ü¿°
  • chronic progressive disciform granulomatosis
    ¸¸¼º ÁøÇ༺ ¿øÆÇ»ó À°¾ÆÁ¾Áõ
  • chronic prostatitis
    ¸¸¼º Àü¸³¼±¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
chronic granulomatous disease <disease> Chronic granulomatous disease is usually fatal in childhood, in which the production of hydrogen peroxide by phagocytes does not occur because of a lesion in an NADP dependent oxidase.
Catalase negative bacteria are not killed and there is no luminol enhanced chemiluminescence when the cells are tested. The absence of the oxygen dependent killing mechanism is not itself fatal but seriously compromises the primary defense system.
at least three separate lesions can cause the syndrome, the commonest being a defect in plasma membrane cytochrome.
Acronym: CGD
(12 Jan 1998)
chronic granulomatous disease of childhood <radiology> Disorder of phagocytosis, two forms: X-linked recessive, autosomal recessive, usually fatal in childhood, infection by nonpathogenic organisms (catalase positive), pneumonia, osteomyelitis, diarrhoea, abdominal pain Findings: recurrent pneumonia (resolves incompletely, with abscess formation), adenopathy (big hila), hepatosplenomegaly, calcified granulomata in liver, spleen, lymph nodes, gastric antral narrowing (!) Cf: Chediak-Higashi syndrome More info: chronic granulomatous disease
(12 Dec 1998)
chronic haemorrhagic villous synovitis <radiology> Monoarthritis, young adults, erosions on BOTH sides of joint (!), probably inflammatory, haemosiderin deposited in synovium, articular cartilage preserved (despite extensive marginal erosions; similar to gout), NO calcification Differential diagnosis: TB (associated atrophy of muscle and bone), rheumatoid arthritis (symmetrical), synovial sarcoma (with or without calcified; outside joint), synovial osteochondromatosis
(12 Dec 1998)
chronic hepatitis Any of several types of hepatitis persisting for more than six months, often progressing to cirrhosis.
Synonym: chronic active liver disease.
(05 Mar 2000)
chronic hypertensive disease The chronic accumulative effects of long-standing high blood pressure on such vital organs as the heart, kidney, and brain.
(05 Mar 2000)
chronic hypertrophic vulvitis Swelling of the vulval tissues due to lymphatic obstruction; in some cases it may be caused by filariasis, with induration or ulceration of the skin.
Synonym: elephantiasis vulvae.
(05 Mar 2000)
chronic hyperventilation syndrome <syndrome> Reduced CO2 content of the blood (hypocapnia) as a result of hyperventilation of prolonged duration; may occur in anxiety states and in some chronic organic, usually cardiovascular, disease; alkalaemia, paresthesia, and tetany may occur.
(05 Mar 2000)
chronic idiopathic jaundice <syndrome> An inherited disorder (autosomal recessive) that is characterised by long-standing mild jaundice. This occurs secondary to an abnormality in the transport of bilirubin from the liver to the biliary system. This leads to an accumulation of bilirubin in the liver. Avoidance of alcohol and medications which can affect the liver is important.
Inheritance: autosomal recessive.
(27 Sep 1997)
chronic idiopathic xanthomatosis Vague or indefinite term for inherited abnormalities of lipid metabolism leading to xanthoma formation (e.g., primary familial xanthomatosis).
(05 Mar 2000)
chronic illness An illness that has persisted for a long period of time. It is a continuing disease process.
(12 Dec 1998)
chronic inflammation An inflammation that may begin with a relatively rapid onset or in a slow, insidious, and even unnoticed manner, tends to persist for several weeks, months, or years and has a vague and indefinite termination; results when the injuring agent (or products resulting from its presence) persists in the lesion, and the host's tissues respond in a manner (or to a degree) that is not sufficient to overcome completely the continuing effects of the injuring agent.
(05 Mar 2000)
chronic inflammatory demyelinating polyneuropathy An uncommon, acquired, demyelinating sensorimotor polyneuropathy, clinically characterised by insidious onset, and slow evolution, (either steady progression or stepwise), and chronic course; symmetrical weakness is a predominant symptom, often involving proximal leg muscles, accompanied by paresthesias, but not pain; CSF examination shows elevated protein, while electrodiagnostic studies reveal evidence of a demyelinating process, primarily conduction slowing rather than block; sometimes responds to prednisone.
(05 Mar 2000)
chronic inflammatory polyneuropathy <neurology, pathology> A disorder that involves the slow progressive (or recurrent) inflammation of multiple nerves. Loss of movement and sensation are common findings. The exact cause is related to an abnormal immune response.
The acute form of this illness is known as Guillain-Barre syndrome. Treatment often includes systemic corticosteroids or chemotherapeutic agents to suppress the immune system. Prognosis is variable.
Origin: Gr. Pathos = disease
(27 Sep 1997)
chronic interstitial hepatitis An obsolete term for cirrhosis of the liver.
(05 Mar 2000)
chronic interstitial hypertrophic neuropathy dejerine-Sottas disease
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á